Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
4
×
life sciences
national blog main
cancer
fda
national top stories
san francisco blog main
alexion pharmaceuticals
cancer drugs
deals
eli lilly
european society for medical oncology
investing
mirati therapeutics
roche
san francisco top stories
89bio
abbvie
adrian krainer
alnylam pharmaceuticals
alzheimer europe conference
alzheimer's disease
amgen
astrazeneca
bain capital
biogen
biotech ipos
black diamond therapeutics
bladder cancer
blueprint medicines
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer immunotherapy
cerevel therapeutics
What
drug
4
×
research
4
×
medicines
biotech
cancer
ipo
targets
alzheimer’s
annual
assessed
attention
bio
black
caught
causing
clinic
communities
companies
conference
despite
diamond
dicerna
disease
eluded
esmo
europe
eye
family
gene
germany
hardest
hepatitis
hit
hopes
hosted
hottest
hunters
intended
investment
lead
Language
unset
Current search:
research
×
drug
×
" clinical trials "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
